arrow
F

Federica Vianello

University of Padua
H指数:27
被引数:3,318

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Flow cytometry, cytology and histology in the diagnosis of ocular hematologic neoplasms: a 15-year monocentric experience with a focus on ocular lymphomas

流式细胞术、细胞学和组织学在眼血液系统肿瘤诊断中的应用:一项以眼淋巴瘤为重点的15年单中心经验

2026-01-290
PRE
Genetic modification of the AJCC classification of papillary thyroid cancer: an international, multicentre, retrospective cohort study

乳头状甲状腺癌AJCC分类的基因修饰:一项国际、多中心、回顾性队列研究

2025-09-290
PRE
Clinical and Pathological Factors Associated with Disease Persistence in Pediatric Patients with Differentiated Thyroid Carcinoma

分化型甲状腺癌患儿疾病持续存在的临床及病理相关因素

Thyroid
IF6.7
2025-07-300
PRE
Baseline prognostic predictors in classical Hodgkin Lymphoma: a retrospective, single-center analysis on patients treated with PET/CT-guided ABVD

经典霍奇金淋巴瘤的基线预后预测因素: PET/CT引导下ABVD治疗患者的回顾性单中心分析

2024-09-050
OAAI
Stereotactic radiotherapy (SRT) for differentiated thyroid cancer (DTC) oligometastases: an AIRO (Italian association of radiotherapy and clinical oncology) systematic review
2022-04-0811
PRE
BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer

BRAF V600E状态可显著区分乳头状甲状腺癌的淋巴结转移相关死亡风险

2021-07-1740
OA
BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinoma

BRAF V600E状态可能有助于对低危甲状腺乳头状微小癌进行主动监测的决策

2020-01-0139
OAAI
A new standardized data collection system for interdisciplinary thyroid cancer management: Thyroid COBRA
2018-07-0128
PREAI
BRAF V600E Mutation-Assisted Risk Stratification of Solitary Intrathyroidal Papillary Thyroid Cancer for Precision Treatment

BRAF V600E突变辅助的孤立性甲状腺内乳头状甲状腺癌风险分层精准治疗

2017-11-1857
OAAI